ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors
Federica Lovisa(Azienda Ospedaliera di Padova), Paolo Bonvini(Directorate-General for Interpretation)
Cited by 9